ESCO Technologies Inc. (NYSE: ESE) reported higher sales, orders and earnings for the fourth quarter and the full fiscal year ended September 30, 2026, the St. Louis-based company announced on Nov. 19, 2026.
Quarterly and full-year highlights
Fourth-quarter sales came to $384 million, up $31 million, or 9 percent, from $353 million in Q4 2025. All of the quarter’s growth was organic, since the ESCO Maritime Solutions (Maritime) acquisition was completed in the third quarter of fiscal 2025.
Fiscal 2026 sales reached $1.3 billion, an increase of $227 million, or 21 percent, from $1.1 billion a year earlier. Organic revenue rose $106 million (10 percent) and Maritime contributed $121 million (11 percent) of inorganic growth for the year.
Q4 2026 GAAP earnings per share from continuing operations were $1.97, up 14 percent from $1.73 in the prior-year quarter. Adjusted EPS from continuing operations rose 15 percent to $2.67 from $2.32.
FY 2026 GAAP EPS from continuing operations advanced 25 percent to $5.63 from $4.49, while Adjusted EPS from continuing operations climbed 40 percent to $8.42 from $6.03.
Entered orders in the quarter totaled $392 million, up $71 million, or 22 percent, for a book-to-bill ratio of 1.02x.
Full-year entered orders grew $172 million, or 11 percent, to $1.7 billion, a book-to-bill of 1.31x, producing a record year-end backlog of $1.5 billion. Organic orders were up $232 million (20 percent).
Net cash provided by operating activities from continuing operations was $102 million in Q4 2026 and $296 million for the fiscal year, $95 million more than in FY 2025.
CEO comment
“ESCO closed fiscal 2026 with strong performance. 2026 has been a very exciting year for ESCO and our financial results have resulted in record orders, sales, adjusted earnings and operating cash flow.
“Our employees’ hard work, expertise, and teamwork drove operational improvements and made this year’s achievements possible, building a strong foundation for continued success. Looking ahead, the addition of Megger, our record backlog, and strong positions in markets with durable long-term growth drivers reinforce our confidence in ESCO’s future.”
The comments came from Bryan Sayler, Chief Executive Officer and President.
Segment performance
Aerospace & Defense (A&D)
Q4 2026 sales rose $19.8 million (12 percent) to $190.2 million from $170.4 million, helped by strength in Navy programs and commercial aerospace. For the full year, sales increased $174.3 million (36 percent) to $652.5 million from $478.2 million, as organic revenue added $53.2 million (12 percent) and Maritime supplied $121.1 million of inorganic growth. Navy, commercial aerospace and military aerospace all contributed to the yearly gains.
Q4 2026 EBIT was $56.4 million, up $9.5 million from $46.9 million. Adjusted EBIT for the quarter rose $7.7 million to $56.4 million, a 29.7 percent margin, from $48.7 million and 28.6 percent a year earlier. FY 2026 EBIT increased $62.6 million to $187.7 million from $125.1 million, and Adjusted EBIT was up $58.4 million at $188.1 million (28.8 percent margin) versus $129.7 million (27.1 percent margin). Higher volume leverage and price increases drove the Adjusted EBIT improvement, partly offset by mix and inflationary pressure in both periods.
Entered orders in the quarter were $193.6 million, up $51.7 million (36 percent), for a book-to-bill of 1.02, with strength in Navy and military aerospace. FY 2026 entered orders increased $59.8 million (7 percent) to $955.4 million (book-to-bill of 1.46), lifting year-end backlog to a record $1.1 billion. Organic orders rose $119.4 million (24.8 percent), with Navy, commercial aerospace and military aerospace leading the yearly gains.
Utility Solutions Group (USG)
Q4 2026 sales were $114.0 million, up $3.8 million (3 percent) from $110.2 million. Doble sales increased $7.2 million (8 percent) while NRG sales fell $3.4 million (20 percent). Growth in the quarter came mainly from higher condition monitoring and services revenue at Doble, partly offset by lower renewables revenue at NRG. FY 2026 sales rose $15.0 million (4 percent) to $395.0 million from $380.0 million, as Doble added $32.7 million (10 percent) and NRG declined $17.7 million (27 percent). Broad strength across Doble’s product lines drove the full-year increase, partly offset by lower NRG renewables revenue.
Q4 2026 EBIT declined $0.7 million to $31.2 million from $31.9 million. Adjusted EBIT fell $0.6 million to $31.4 million (27.5 percent margin) from $32.0 million (29.1 percent margin), reflecting deleverage on lower NRG volume, inflation and mix, partly offset by price increases and leverage on higher Doble volume. FY 2026 EBIT rose $0.5 million to $95.2 million from $94.7 million, and Adjusted EBIT increased $1.1 million to $96.3 million (24.4 percent margin) from $95.2 million (25.0 percent margin). The full-year improvement came from leverage on higher Doble volume and price increases, partly offset by lower NRG volume and inflation.
Q4 2026 entered orders increased $11.8 million (10 percent) to $128.0 million (book-to-bill of 1.12). Doble orders rose $11.6 million (11 percent) to $112.9 million and NRG orders edged up $0.2 million (1 percent) to $15.1 million. FY 2026 entered orders grew $51.4 million (13 percent) to $454.9 million (book-to-bill of 1.15), leaving year-end backlog of $203.4 million. Doble orders rose $64.3 million (19 percent) for the year while NRG orders fell $12.9 million (20 percent). In both periods, orders reflected broad strength across Doble’s product lines as electric utilities invested in grid maintenance and expansion, partly offset by lower renewables business after the expiration of U.S. tax credits.
As previously announced, the Megger transaction closed on October 1, 2026. Integration planning started during the regulatory approval process, and work on those plans and on cost reduction initiatives is now under way.
RF Test & Measurement (Test)
Q4 2026 sales increased $7.7 million (11 percent) to $79.8 million from $72.1 million, and FY 2026 sales rose $37.3 million (16 percent) to $274.5 million from $237.2 million. Military and automotive projects, filters for U.S. government data centers and secure facilities, and industrial and medical shielding drove growth in both periods.
Q4 2026 EBIT was $13.2 million, up $0.6 million from $12.6 million. Adjusted EBIT for the quarter increased $1.3 million to $13.9 million (17.5 percent margin) from $12.6 million (17.5 percent margin). FY 2026 EBIT rose $6.8 million to $40.9 million from $34.1 million, and Adjusted EBIT increased $9.1 million to $43.7 million (15.9 percent margin) from $34.6 million (14.6 percent margin). Leverage on higher volume and price increases lifted Adjusted EBIT in both periods, partly offset by inflation.
Q4 2026 entered orders rose $7.9 million (13 percent) to $70.7 million, led by a large automotive order and several military projects, partly offset by lower wireless and medical shielding. FY 2026 entered orders grew $61.2 million (23 percent) to a record $326.9 million (book-to-bill of 1.19), producing record year-end backlog of $239.6 million. Military and automotive projects, filters for U.S. government data centers and secure facilities, and industrial shielding drove the yearly gains.
Income statement, balance sheet and cash flow detail
Consolidated net sales for Q4 2026 were $383,994 thousand against $352,674 thousand a year earlier. Cost of sales was $226,596 thousand (Q4 2025: $203,235 thousand), selling, general and administrative expenses were $64,945 thousand ($63,333 thousand), amortization of intangible assets was $20,286 thousand ($20,582 thousand) and interest expense was $3,103 thousand ($5,129 thousand). Pretax earnings were $67,793 thousand ($59,567 thousand), income tax expense was $16,574 thousand ($14,713 thousand) and earnings from continuing operations were $51,219 thousand ($44,854 thousand). Including a $129 thousand loss from discontinued operations, net earnings were $51,090 thousand, compared with $218,652 thousand in Q4 2025.
For FY 2026, net sales were $1,322,021 thousand versus $1,095,388 thousand. Pretax earnings were $188,089 thousand ($152,853 thousand), tax expense was $41,888 thousand ($36,554 thousand), earnings from continuing operations were $146,201 thousand ($116,299 thousand) and net earnings, including $1,048 thousand from discontinued operations, were $147,249 thousand compared with $299,223 thousand.
Adjusted net earnings were $69.3 million in Q4 2026, excluding $18.1 million (or $0.70 per share) of after-tax charges: $0.18 of debt financing and acquisition costs at Corporate tied to the Megger acquisition and $0.52 of acquisition related amortization. Q4 2025 adjusted net earnings were $60.0 million, excluding $15.2 million ($0.59 per share) made up of $0.05 of Maritime inventory step-up charges, $0.01 of restructuring charges (mainly severance) in USG and $0.53 of acquisition related amortization. For FY 2026, adjusted net earnings were $218.7 million, excluding $72.5 million ($2.79 per share) consisting of $0.09 of restructuring charges in the Test, USG and A&D segments, $0.61 of debt financing and acquisition costs at Corporate related to Megger and $2.09 of acquisition related amortization. FY 2025 adjusted net earnings were $156.4 million, excluding $40.1 million ($1.54 per share) of Corporate acquisition costs ($0.15), Maritime inventory step-up charges and stamp duties ($0.14), restructuring charges in Test and USG ($0.02) and acquisition related amortization ($1.23).
Consolidated EBITDA was $97,467 thousand in Q4 2026 ($91,316 thousand in Q4 2025) and $311,828 thousand for FY 2026 ($245,376 thousand), or $101,368 thousand and $326,550 thousand respectively on an adjusted basis. Depreciation and amortization totaled $26,571 thousand in the quarter and $106,644 thousand for the year.
At September 30, 2026, cash and cash equivalents were $93.3 million versus $101.4 million a year earlier, and total assets were $2.42 billion against $2.41 billion. Long-term debt stood at $14.0 million, down from $166.0 million, with no current maturities (September 30, 2025: $20.0 million). Shareholders’ equity rose to $1.68 billion from $1.54 billion.
Net cash provided by operating activities from continuing operations was $295.6 million in FY 2026 compared with $200.4 million in FY 2025, while discontinued operations used $58.9 million (FY 2025: $41.5 million provided), for total operating cash flow of $236.7 million versus $241.9 million. Capital expenditures were $34.1 million, additions to capitalized software and other items were $11.1 million and dividends paid were $8.3 million.
Business outlook for fiscal 2027
ESCO’s expectations for FY 2027 growth compared with FY 2026:
Consolidated net sales are projected to rise 55 to 58 percent to a range of $2.05 billion to $2.09 billion, with A&D up 7 to 9 percent, USG up 170 to 175 percent (7 to 9 percent organic growth plus Megger revenue of $640 million to $660 million) and Test up 5 to 7 percent.
Adjusted EBIT is expected to grow about 51 to 55 percent, with Adjusted EBIT margins of 21.2 to 21.8 percent of sales.
Adjusted EBITDA is expected to increase roughly 53 to 57 percent, at margins of 24.2 to 24.8 percent of sales.
Interest is forecast at $61 million to $63 million.
The effective income tax rate is expected to be about 22.5 percent.
FY 2027 Adjusted EPS is expected to rise 12 to 15 percent to a range of $9.40 to $9.70 per share.
Q1 2027 Adjusted EPS is expected to be $1.85 to $1.95 per share, 13 to 19 percent above Q1 2026.
As in prior years, revenues and Adjusted EPS are expected to grow sequentially through the year.
Dividend and annual meeting
The next quarterly cash dividend of $0.08 per share is payable January 19, 2027 to stockholders of record on January 4, 2027. The 2027 Annual Meeting of shareholders will be held on January 29, 2027.
Conference call
ESCO will discuss its Q4 2026 results on a conference call today, November 19, at 4:00 p.m. Central Time. A live audio webcast and accompanying slide presentation will be available in the Investor Center of ESCO’s website, and participants can also join the webcast through this registration link. A replay will be posted in the Investor Center after the call.
VACCO divestiture
ESCO sold VACCO Industries during Q4 2025. VACCO’s operating results are reported as Discontinued Operations in the accompanying tables and are excluded from the discussion of results from Continuing Operations for the comparable periods.
Forward-Looking Statements
Statements in this press release regarding Management’s intentions, expectations and guidance for fiscal 2027, including restructuring and cost reduction actions, sales, orders, revenues, margin, earnings, Adjusted EPS, acquisition related amortization, and any other statements which are not strictly historical, are “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. securities laws.
Investors are cautioned that such statements are only predictions and speak only as of the date of this release, and the Company undertakes no duty to update them except as may be required by applicable laws or regulations. The Company’s actual results in the future may differ materially from those projected in the forward-looking statements due to risks and uncertainties that exist in the Company’s operations and business environment including but not limited to those described in Item 1A, “Risk Factors”, of the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2025 and the following: the impacts of climate change and related regulation of greenhouse gases; the impacts of labor disputes, civil disorder, wars, including the conflicts involving Iran and Lebanon, elections, political changes, tariffs and trade disputes, terrorist activities, cyberattacks or natural disasters on the Company’s operations and those of the Company’s customers and suppliers; disruptions in manufacturing or delivery arrangements due to shortages or unavailability of materials or components; restrictions or closures of critical supply routes such as the Strait of Hormuz; other supply chain disruptions; inability to access work sites; the timing and content of future contract awards or customer orders; the timely appropriation, allocation and availability of Government funds; the termination for convenience of Government and other customer contracts or orders; weakening of economic conditions in served markets; the success of the Company’s competitors; changes in customer demands or customer insolvencies; competition; intellectual property rights; technical difficulties or data breaches; the availability of acquisitions; delivery delays or defaults by customers; performance issues with key customers, suppliers and subcontractors; material changes in the costs and availability of certain raw materials; material changes in the cost of credit; changes in laws and regulations including but not limited to changes in accounting standards and taxation; changes in interest, inflation and employment rates; costs relating to environmental matters arising from current or former facilities; uncertainty regarding the ultimate resolution of current disputes, claims, litigation or arbitration; and the integration and performance of acquired businesses.
Non-GAAP Financial Measures
The release presents EBIT, Adjusted EBIT, EBITDA, Adjusted EBITDA and Adjusted EPS. ESCO defines “EBIT” as earnings before interest and taxes, “EBITDA” as earnings before interest, taxes, depreciation and amortization, “Adjusted EBIT” and “Adjusted EBITDA” as excluding the net impact of the items described in the attached Reconciliation of Non-GAAP Financial Measures, and “Adjusted EPS” as GAAP earnings per share excluding the net impact of the items described and reconciled there.
EBIT, Adjusted EBIT, EBITDA, Adjusted EBITDA and Adjusted EPS are not recognized in accordance with U.S. generally accepted accounting principles (GAAP). However, Management believes EBIT, Adjusted EBIT, EBITDA, and Adjusted EBITDA are useful in assessing the operational profitability of the Company’s business segments because they exclude interest, taxes, depreciation, and amortization, which are generally accounted for across the entire Company on a consolidated basis. EBIT is also one of the measures used by Management in determining resource allocations within the Company as well as incentive compensation. The presentation of EBIT, Adjusted EBIT, EBITDA, Adjusted EBITDA, and Adjusted EPS provides important supplemental information to investors by facilitating comparisons with other companies, many of which use similar non-GAAP financial measures to supplement their GAAP results. The use of non-GAAP financial measures is not intended to replace any measures of performance determined in accordance with GAAP.
About ESCO
ESCO Technologies is a global provider of highly engineered products and solutions serving diverse end-markets. It manufactures filtration and fluid control products, advanced composites, as well as signature and power management solutions for aviation, Navy, and industrial customers. ESCO is an industry leader in designing and manufacturing RF test and measurement products and systems; and provides diagnostic instruments, software and services to industrial power users and the electric utility and renewable energy industries. Headquartered in St. Louis, Missouri, ESCO and its subsidiaries have offices and manufacturing facilities worldwide. For more information on ESCO and its subsidiaries, visit ESCO’s website at www.escotechnologies.com.
SOURCE ESCO Technologies Inc. Kate Lowrey, Vice President of Investor Relations, (314) 213-7277